Oramed Pharmaceuticals (ORMP) Other Gross PP&E Adjustments (2022 - 2025)
Oramed Pharmaceuticals' Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$873000.0 for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments changed N/A year-over-year to -$873000.0; the TTM value through Dec 2025 reached -$873000.0, changed N/A, while the annual FY2025 figure was -$873000.0, N/A changed from the prior year.
- Other Gross PP&E Adjustments reached -$873000.0 in Q4 2025 per ORMP's latest filing, down from -$817000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$342000.0 in Q1 2025 to a low of -$1.3 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 4 years is -$905933.3, with a median of -$976000.0 recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 53.04% in 2024, then crashed 68.11% in 2025.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$1.3 million in 2022, then grew by 23.63% to -$976000.0 in 2023, then skyrocketed by 50.2% to -$486000.0 in 2024, then plummeted by 79.63% to -$873000.0 in 2025.
- Per Business Quant, the three most recent readings for ORMP's Other Gross PP&E Adjustments are -$873000.0 (Q4 2025), -$817000.0 (Q3 2025), and -$882000.0 (Q2 2025).